Racial/ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer

Journal of Clinical Oncology

Volumn 22, Issue 20, 2004, Pages 4193-4201

  Johnson, Terri Kang ^a   Gilliland, Frank D ^a   Hoffman, Richard M ^a   Deapen, Dennis ^a   Penson, David F ^a   Stanford, Janet L ^a   Albertsen, Peter C ^a   Hamilton, Ann S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CONVALESCENCE; ETHNIC DIFFERENCE; HISPANIC; HUMAN; INTESTINE FUNCTION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; SCORING SYSTEM; SEXUAL FUNCTION; TREATMENT OUTCOME; URINARY TRACT FUNCTION; URINE INCONTINENCE; AGED; ETHNIC GROUP; ETHNOLOGY; IMPOTENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSTATE TUMOR;

AFRICAN AMERICANS; AGED; COHORT STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISPANIC AMERICANS; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; URINARY INCONTINENCE;

EID: 7044220504     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.09.127     Document Type: Article

References (31)

1. Jemal A, Thomas A, Murray T, et al: Cancer statistics, 2002. CA Cancer J Clin 52:23-47, 2002
2. Etzioni R, Penson DF, Legler JM, et al: Over-diagnosis due to prostate-specific antigen screening: Lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94:981-990, 2002
3. Partin AW, Kattan MW, Subong EN, et al: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multiinstitutional update. JAMA 277:1445-1451, 1997
4. Yarbro CH, Ferrans CE: Quality of life of patients with prostate cancer treated with surgery or radiation therapy. Oncol Nurs Forum 25:685-693, 1998
5. Lim AJ, Brandon AH, Fiedler J, et al: Quality of life: Radical prostatectomy versus radiation therapy for prostate cancer. J Urol 154:1420-1425, 1995
6. Fowler FJ Jr, Barry MJ, Lu-Yao G, et al: Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol 14:2258-2265, 1996
7. Beard CJ, Propert KJ, Rieker PP, et al: Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: A prospective multiinstitutional outcomes study. J Clin Oncol 15:223-229, 1997
8. Dale W, Campbell T, Ignacio L, et al: Self-assessed health-related quality of life in men being treated for prostate cancer with radiotherapy: Instrument validation and its relation to patient-assessed bother of symptoms. Urology 53:359-366, 1999
9. Lubeck DP, Litwin MS, Henning JM, et al: Changes in health-related quality of life in the first year after treatment for prostate cancer: Results from CaPSURE. Urology 53:180-186, 1999
10. Shrader-Bogen CL, Kjellberg JL, McPherson CP, et al: Quality of life and treatment outcomes: Prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer 79:1977-1986, 1997
11. Litwin MS, Hays RD, Fink A, et al: Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273:129-135, 1995
12. Lilleby W, Fossa SD, Waehre HR, et al: Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 43:735-743, 1999
13. McCammon KA, Kolm P, Main B, et al: Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 54:509-516, 1999
14. Steineck G, Helgesen F. Adolfsson J, et al: Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347:790-796, 2002
15. Lubeck DP, Kim H, Grossfeld G, et al: Health related quality of life differences between black and white men with prostate cancer: Data from the cancer of the prostate strategic urologic research endeavor. J Urol 166:2281-2285, 2001
16. Potosky AL, Harlan LC, Stanford JL, et al: Prostate cancer practice patterns and quality of life: The Prostate Cancer Outcomes Study. J Natl Cancer Inst 91:1719-1724, 1999
17. Grossfeld GD, Latini DM, Downs T. et al: Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy? J Urol 168:2510-2515, 2002
18. Stanford J, Feng Z, Hamilton A, et al: Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 283:354-360, 2000
19. Hamilton AS, Stanford JL, Gilliland FD, et al: Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: Results from the Prostate Cancer Outcomes Study. J Clin Oncol 19:2517-2526, 2001
20. Potosky A, Legler J, Albertsen P, et al: Health outcomes after radical prostatectomy or radiotherapy for clinically localized prostate cancer: Results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 92:1582-1592, 2000
21. Talcott JA, Rieker P, Clark JA, et al: Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study. J Clin Oncol 16:275-283, 1998
22. Fowler FJ Jr, Barry MJ, Lu-Yao G, et al: Patient-reported complications and follow-up treatment after radical prostatectomy: The National Medicare Experience - 1988-1990. Urology 42:622-629, 1993
23. Litwin MS, Hays RD, Fink A, et al: The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med Care 36:1002-1012, 1998
24. Legler J, Potosky A, Gilliland F, et al: The Prostate Cancer Outcomes Study (PCOS) methods: Validation study of retrospective recall of disease-targeted function. Med Care 38:847-857, 2000
25. Cohen J: Statistical Power Analysis for the Behavioral Sciences. New York, NY, Academic Press, 1977
26. Cykert S, Joines JD, Kissling G, et al: Racial differences in patients' perceptions of debilitated health states. J Gen Intern Med 14:217-222, 1999
27. Cross CK, Shultz D, Malkowicz SB, et al: Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate. J Clin Oncol 20:2863-2868, 2002
28. Johnstone PA, Kane CJ, Sun L, et al: Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: Radiation oncology report of the Department of Defense Center for Prostate Disease Research. Radiology 225:420-426, 2002
29. Roach M 3rd, Lu J, Pilepich MV, et al: Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials. J Urol 169:245-250, 2003
30. Bianco FJ Jr, Wood DP Jr., Grignon DJ, et al: Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy. J Urol 168:479-482, 2002
31. Rothman K: No adjustments are needed for multiple comparisons. Epidemiology 1:43-46, 1990